Zobrazeno 1 - 10
of 57
pro vyhledávání: '"C A, HUBAY"'
Autor:
J P, Crowe, N H, Gordon, C A, Hubay, R R, Shenk, R M, Zollinger, D J, Brumberg, W L, McGuire, J M, Shuck
Publikováno v:
Surgery, gynecologyobstetrics. 173(4)
To investigate whether or not hormone receptor determination gives independent prognostic information for long term survival of patients with carcinoma of the breast, we studied 1,392 patients with early carcinoma of the breast. Patients were part of
Autor:
J P, Crowe, N H, Gordon, R R, Shenk, R W, Soegiarso, C A, Hubay, E G, Mansour, J M, Shuck, O H, Pearson, J S, Marshall, B, Arafah
Publikováno v:
Surgery. 108(4)
Three hundred eleven patients with node-positive breast cancer were randomized to one of three adjuvant treatments: cyclophosphamide (Cytoxan), methotrexate, and 5-fluorouracil; all of the above with tamoxifen citrate; or all of the above with tamoxi
Publikováno v:
International Journal of Cancer. 16:905-913
The leukocyte adherence inhibition (LAI) method was studied with respect to its specificity in detecting responses to extracts of tumor tissues or normal lymphocytes. Responses of cells from normal persons were within 10% of each other whether incuba
Publikováno v:
The Journal of Immunology. 92:73-81
Summary The effects of a partially purified transfer factor (PTF) on specific guinea pig skin homografts has been described. There is a significant increase in the rate of rejection of such grafts, compared with controls. PTF taken from nonspecifical
Publikováno v:
Surgical forum. 27(62)
Autor:
C A, Hubay, N H, Gordon, J P, Crowe, S P, Guyton, O H, Pearson, J S, Marshall, E G, Mansour, R E, Hermann, J C, Jones, W J, Flynn
Publikováno v:
Surgery. 96(1)
A prospective, randomized clinical trial of adjuvant treatment of 312 stage II breast cancer patients with use of chemotherapy, antiestrogen therapy, and immunotherapy is reported after 72 months of follow-up. The stratification of patients was based
Autor:
C A, Hubay, O H, Pearson, J S, Marshall, T A, Stellato, R S, Rhodes, S M, DeBanne, J, Rosenblatt, E G, Mansour, R E, Hermann, J C, Jones, W J, Flynn, C, Eckert, W L, McGuire
Publikováno v:
Breast cancer research and treatment. 1(1)
A prospective, randomized clinical trial of adjuvant treatment of 318 stage II breast cancer patients, using chemotherapy, the antiestrogen tamoxifen, and immunotherapy is reported at 48 months follow-up. Women whose primary tumors have no estrogen r
Autor:
F W, Lafferty, C A, Hubay
Publikováno v:
Archives of internal medicine. 149(4)
We studied long-term morbidity after parathyroid surgery for primary hyperparathyroidism in 100 patients and compared it with the long-term morbidity of medical follow-up from the literature. The surgical treatment of primary hyperparathyroidism was
Autor:
C A, Hubay, O H, Pearson, J S, Marshall, R S, Rhodes, S M, Debanne, E G, Mansour, R E, Hermann, J C, Jones, W J, Flynn, C, Eckert, W L, McGuire
Publikováno v:
Surgery. 87(5)
A prospective, randomized clinical trial of three treatment regimens: (1) Cytoxan, methotrexate, and 5-fluorouracil (CMF), (2) CMF plus the antiestrogen drug, tamoxifen (CMFT), and (3) CMFT plus bacillus Calmette-Guerin (BCG) vaccinations in women wi
Publikováno v:
The Journal of laboratory and clinical medicine. 109(3)
Results of a prospective, randomized clinical trial of three treatment regimens--cyclophosphamide, methotrexate, and 5-fluorouracil (C); C plus the antiestrogen, tamoxifen citrate (CT); and CT plus bacillus Calmette-Guerin (CTBCG)--in 311 women with